title: Lipoprotein (a): a promising target in the treatment of stenotic valvular diseases.
authors.affiliation: Québec Heart and Lung Institute/Institut Universitaire de Cardiology et de Pneumologie de Québec, 2725 Chemin Sainte-Foy, Québec, Canada G1V-4G5 philippe.pibarot@med.ulaval.ca.
authors.forename: Philippe
authors.initials: P
authors.lastname: Pibarot
authors.affiliation: Department of Cardiology, Medical University of Vienna, Vienna, Austria.
authors.forename: Raphael
authors.initials: R
authors.lastname: Rosenhek
authors.affiliation: GIGA Cardiovascular Sciences, Department of Cardiology, Heart Valve Clinic, CHU Sart Tilman, University of Liège Hospital, Liège, Belgium Gruppo Villa Maria Care and Research, Anthea Hospital, Bari, Italy.
authors.forename: Patrizio
authors.initials: P
authors.lastname: Lancellotti
mesh_terms: D001021:Aortic Valve; D004696:Endocarditis; D006349:Heart Valve Diseases; D006801:Humans; D017270:Lipoprotein(a)
chemical_list: D017270:Lipoprotein(a)